These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2391694)

  • 1. Aqua[1-(2,6-dichloro-4-hydroxyphenyl)-2- phenylethylenediamine](sulfato)platinum-(II) complexes with variable substituents in the 2-phenyl ring. 1. Synthesis and antitumor and estrogenic properties.
    Gust R; Burgemeister T; Mannschreck A; Schönenberger H
    J Med Chem; 1990 Sep; 33(9):2535-44. PubMed ID: 2391694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in the 2-phenyl ring. 3. Investigation of breast cancer inhibiting properties.
    Gust R; Faderl M; Schönenberger H
    J Cancer Res Clin Oncol; 2000 Nov; 126(11):647-54. PubMed ID: 11079729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Third generation antitumor platinum(II) complexes of the [1-(fluoro/difluorophenyl)-2-phenylethylenediamine]platinum(II) type.
    Gust R; Schönenberger H
    Arch Pharm (Weinheim); 1995; 328(7-8):595-603. PubMed ID: 7492264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aqua[1-(2,6-dichloro-4-hydroxyphenyl)-2- phenylethylenediamine]sulfatoplatinum(II) complexes with variable substituents in the 2-phenyl ring, II: Correlation of molecular structure and estrogenic activity of breast and prostate cancer inhibiting. [erythro-1-(2,6-dichloro-4-hydroxyphenyl)-2-(2-halo-4- hydroxyphenyl)ethylenediamine]platinum(II) complexes.
    Gust R; Schönenberger H; Klement U; Range KJ
    Arch Pharm (Weinheim); 1993 Dec; 326(12):967-76. PubMed ID: 8122966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aqua[1,1-bis(4-hydroxyphenyl)-1,2-diamino-2-phenylethane]- sulfatoplatinum(II), a new compound for the treatment of the mammary carcinoma.
    Gust R
    Arch Pharm (Weinheim); 1994 Jan; 327(1):49-54. PubMed ID: 8117188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes--new biological response modifiers for the therapy of breast cancer. Synthesis and evaluation of estrogenic/antiestrogenic properties.
    Schertl S; Hartmann RW; Batzl-Hartmann C; Schlemmer R; Spruss T; Bernhardt G; Gust R; Schönenberger H
    Arch Pharm (Weinheim); 2001 Apr; 334(4):125-37. PubMed ID: 11382148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between reduction properties and cancer cell growth inhibitory activities of cis-dichloro- and cis-diiodo-Pt(IV)-ethylenediamines.
    Kratochwil NA; Bednarski PJ
    Arch Pharm (Weinheim); 1999 Aug; 332(8):279-85. PubMed ID: 10489538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammary tumor inhibiting [1,2-bis(2,6-dihalo-3-hydroxyphenyl)ethylenediamine]platinum(II) complexes, III: Relationship between structure and estrogenic activity of the diamine ligands, their sulfatoplatinum(II) and diiodoplatinum(II) complexes.
    Gust R; Schönenberger H
    Arch Pharm (Weinheim); 1993 Jul; 326(7):405-13. PubMed ID: 8357303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum and palladium complexes containing ethylenediamine derivatives as carrier ligands and their antitumor activity.
    Lee K; Tashiro T; Noji M
    Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):702-3. PubMed ID: 8004720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor inhibiting [1,2-bis(difluorophenyl)ethylenediamine]dichloroplatinum (II) complexes, I: Synthesis.
    Müller R; Schickaneder E; Jennerwein M; Reile H; Spruss T; Engel J; Schönenberger H
    Arch Pharm (Weinheim); 1991 Feb; 324(2):115-20. PubMed ID: 1854235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the configurational and conformational influences on the hormonal activity of 1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamines and of their platinum(II) complexes. 1. Synthesis, estradiol receptor affinity, and estrogenic activity of diastereomeric [N-alkyl- and N,N'-dialkyl-1,2- bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) complexes.
    Gust R; Niebler K; Schönenberger H
    J Med Chem; 1995 Jun; 38(12):2070-9. PubMed ID: 7783138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unsymmetrical C-substituted ethylenediamine platinum coordination complexes: synthesis and activity against mouse leukemia L1210.
    Hall LM; Speer RJ; Ridgway HJ; Norton SJ
    J Inorg Biochem; 1979 Oct; 11(2):139-49. PubMed ID: 501351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of ring substituents on the antitumor effect of dichloro(1,2-diphenylethylenediamine)platinum(II) complexes.
    Jennerwein M; Wappes B; Gust R; Schönenberger H; Engel J; Seeber S; Osieka R
    J Cancer Res Clin Oncol; 1988; 114(4):347-58. PubMed ID: 3410875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexes.
    Kim DK; Kim G; Gam J; Cho YB; Kim HT; Tai JH; Kim KH; Hong WS; Park JG
    J Med Chem; 1994 May; 37(10):1471-85. PubMed ID: 8182706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and cytotoxicity of enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)-3-methylbutane]platinum(II) complexes.
    Dullin A; Dufrasne F; Gelbcke M; Gust R
    ChemMedChem; 2006 Jun; 1(6):644-53. PubMed ID: 16892405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the conformational influences on the estrogenic activity of 1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamines and of their platinum(II) complexes, II: Synthesis and studies on the estrogenic activity of cis- and trans[bis(2,6-dichloro-4-hydroxybenzylamine)]dihaloplatinum(II)-c omplexes.
    Gust R; Schönenberger H
    Arch Pharm (Weinheim); 1994 Dec; 327(12):763-9. PubMed ID: 7872853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-directed alkylating agents. 2. Synthesis and biological activity of platinum complexes linked to 9-anilinoacridine.
    Palmer BD; Lee HH; Johnson P; Baguley BC; Wickham G; Wakelin LP; McFadyen WD; Denny WA
    J Med Chem; 1990 Nov; 33(11):3008-14. PubMed ID: 2231598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dichloro-[1-(hydroxyphenyl)-2-phenylethylenediamine]platinum(II) complexes: testing on the human ovarian cancer cell lines NIH: OVCAR3 and SK OV 3.
    Bernhardt G; Müller R; Gust R; Reile H; Keller C; Spruss T; Schönenberger H
    Arch Pharm (Weinheim); 1992 Feb; 325(2):93-9. PubMed ID: 1605722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, conformational studies, and investigations on the estrogen receptor binding of [R/S-1-(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]platinum(II) complexes.
    Gust R; Lubczyk V; Schmidt K; Shihada U
    Arch Pharm (Weinheim); 2001 Mar; 334(3):93-100. PubMed ID: 11315340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New platinum (II) and platinum (IV) complexes with 1,2-diaminocyclohexane. Synthesis and in vitro and in vivo antitumour evaluation.
    Craciunescu DG; Furlani Candiani A; Scarcia V; Doadrio A; Ghirvu C
    J Pharm Belg; 1985; 40(2):79-84. PubMed ID: 4009393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.